Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-06

Clinical Trial Update: Rapid Infusion of Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating rapid infusion of ofatumumab in patients with previously treated chronic lymphocytic leukemia; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ofatumumab (ofatumumab)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2017-06-06